Advicenne announces the transfer of its shares from Euronext Paris and Euronext Brussels to Euronext Growth Paris on March 30, 2022

March 28, 2022

Paris, 28 March 2022 – 8.00 am CET – Advicenne, a pharmaceutical company specializing in the development and commercialization of innovative treatments for people suffering from rare kidney diseases, today announced the transfer of the listing of its shares to the Euronext Growth Paris multilateral trading facility on March 30, 2022. The request has been approved by the Admission Committee of Euronext on Mars 24, 2022.